Heilmann L, Buchholz F G
Arch Gynecol. 1978 Nov 30;226(3):251-60. doi: 10.1007/BF02108907.
The relative flow rate of the red blood cells in a hematocrit of 10% was measured with a 5 mu nuclepore filter system. The influence of Partusisten was determined by the alteration of the red blood cells. The in vitro concentration of 0.1 ng Partusisten/ml blood resulted in a relative improvement of the flow rate, which we also found in normal pregnancies. However, in a vivo concentration of 4 microgram intravenous Partusisten/min for 48 h, the red cell alteration properties decreased. After a greater time interval, the red blood cells alteration was about the same as in the pre-drug level. The uteroplacental perfusion changed in dependence to the concentration of the beta-mimetic drug (Partusisten). The presence of rigid red blood cells can be first seen in the microcirculation impairment. Depending on the concentration of Partusisten, a protective effect on the flow properties of the red blood cells could be achieved, which altered during pregnancy. However, in late gestosis, a lower dosage should be administered than in labor inhibition.
使用5微米核孔滤器系统测量了血细胞比容为10%时红细胞的相对流速。通过红细胞的变化来确定Partusisten的影响。体外浓度为0.1纳克Partusisten/毫升血液时,流速相对提高,这在正常妊娠中也有发现。然而,静脉内以每分钟4微克Partusisten的体内浓度持续48小时后,红细胞变化特性降低。更长时间间隔后,红细胞变化与用药前水平大致相同。子宫胎盘灌注随β-拟交感神经药物(Partusisten)浓度而变化。僵硬红细胞首先出现在微循环障碍中。根据Partusisten的浓度,可以对孕期发生变化的红细胞流动特性产生保护作用。然而,在晚期妊娠中毒症中,给药剂量应低于抑制宫缩时的剂量。